Companies / Journey Medical Corp

Journey Medical Corp

Nasdaq: DERMCIK 1867066SCOTTSDALE, AZ

Financials · FY2025

Revenue$61.86M
Net income$-11.43M
Total debt$25.47M
Cash$25.64M
Diluted EPS$-0.47
Shares outstanding28.2M

Ownership

28.2M shares outstanding · as of Aug 11, 2026
0.42%Insiders
Ownership
78.7%Class M
Share classes
Class M78.74%
Class A21.26%
Insiders0.42%118,618
Institutions35.67%10,067,411
Public float63.91%18,038,366

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Herskowitz NeilDirector
0.42%118,618

Institutional holders 80

View all →
HolderValue% of shares
Wasatch Advisors LP$10.15M4.66%
Tang Capital Management, LLC$7.55M5.70%
Opaleye Management Inc.$7.52M3.45%
J. Goldman & Co LP$6.16M2.83%
Vanguard Group Inc$5.89M2.71%
Pale Fire Capital SE$3.43M1.58%
Summit Financial, LLC$3.01M1.38%
Essex Investment Management Co LLC$2.67M1.23%
UBS Group AG$2.24M1.03%
Geode Capital Management, LLC$2.17M1.64%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 25, 2026Herskowitz Neil
Director
GrantCommon Stock, $0.0001 par value$0+10K
+9.21%
118,618
0.42% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DERMCommon StockEquity48115J109BBG00ZWVDRK2